Analytical Data
-
基因名
BAT4
- Application
-
别名
BARX1Homeobox Protein BarH-like 1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9HBU1
-
表达区间
1-356aa
-
氨基酸序列
MSRPLLITFTPATDPSDLWKDGQQQPQPEKPESTLDGAAARAFYEALIGDESSAPDSQRSQTEPARERKRKKRRIMKAPAAEAVAEGASGRHGQGRSLEAEDKMTHRILRAAQEGDLPELRRLLEPHEAGGAGGNINARDAFWWTPLMCAARAGQGAAVSYLLGRGAAWVGVCELSGRDAAQLAEEAGFPEVARMVRESHGETRSPENRSPTPSLQYCENCDTHFQDSNHRTSTAHLLSLSQGPQPPNLPLGVPISSPGFKLLLRGGWEPGMGLGPRGEGRANPIPTVLKRDQEGLGYRSAPQPRVTHFPAWDTRAVAGRERPPRVATLSWREERRREEKDRAWERDLRTYMNLEF
-
分子量
65.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on BAT4 recombinant proteins has gained significant attention in recent years due to their potential applications in biotechnology and medicine. BAT4, a novel protein identified in various biological systems, plays a critical role in immune modulation and cellular processes. Initial studies suggested that BAT4 may enhance immune responses, making it a candidate for developing vaccines and immunotherapies. Additionally, the protein’s unique structure and functional properties prompt interest in its enzymatic activities, which could be leveraged for industrial applications, such as biocatalysis. As researchers continue to explore the mechanisms of BAT4 action, recombinant technology allows for the mass production of these proteins, enabling detailed studies on their efficacy and safety. This line of research also opens up possibilities for engineering BAT4 variants with optimized properties for specific applications. Thus, understanding BAT4 at the molecular level not only contributes to fundamental biological knowledge but also paves the way for innovative solutions in therapeutic strategies, highlighting the importance of these recombinant proteins in the intersection of biology and technology.
